Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications - Wikidata - awgldk - TriplyDB

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

http://www.wikidata.org/entity/Q28079823

about

Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model.Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplanta Optimisation of a potency assay for the assessment of immunomodulative potential of clinical grade multipotent mesenchymal stromal cells.The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate.Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report.Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study.

P2860

Q33755190-478EF84A-AED8-4CCA-9000-D3E6DB944CEA Q47548197-1379F391-0F86-40DF-A730-02DF008DC6F5 Q47596812-86C7EEE2-57A4-476B-B6BB-43AD539F85E9 Q48265135-0CC0859C-AC1A-47D2-B54D-B737C685E0A3 Q49332525-F74D4656-4D20-41F2-8231-12ADE77A6705 Q49383236-D1FA8607-ACAA-4B39-BE50-519450309C66 Q55319551-D65881AC-701C-434C-8644-81715732F6F5

P2860

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

http://www.wikidata.org/entity/Q28079823

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@ast

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@en

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@nl

type

label

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@ast

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@en

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@nl

prefLabel

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@ast

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@en

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@nl

P1433

Q28079823-B629E2A3-A3D7-4DE9-8A0D-D8757974CEE6

P1476

Q28079823-38E7ABCE-DB1C-4165-B12D-76107DF18EB0

P2093

Q28079823-2DA52BE1-B12A-41FC-A7EA-5049ED48E1E5

Q28079823-63AF5DF3-93F9-4EE7-8159-7E65DB7927FE

Q28079823-65CEA034-988B-44E5-B200-2A911BE7CE32

Q28079823-6C7626B5-718A-44D1-8EDE-C676F5EE64D3

Q28079823-88AF0F6B-5114-4676-89B1-43F7ADBE94E3

Q28079823-8AC958B6-95FD-4F7E-9736-ECF98FB7B08F

Q28079823-93B29E2D-2CAC-49DA-9F35-AFB7E9D40999

Q28079823-AEE5ED61-32BB-4BCA-9530-A66932734C5B

Q28079823-D231A1F2-9F2F-4FE7-8A05-8EB7F5F15248

Q28079823-DD14942D-7FA9-4087-8A4D-9EE6257A6950

P2860

Q28079823-00835221-3090-400C-9339-7070DF35EB48

Q28079823-02458E7A-BC06-439B-B6DF-E025728C92A2

Q28079823-0278FACF-85F9-4B59-90FF-B96095BBB508

Q28079823-033CD2E2-DF8F-40CB-AD44-8FF6752207C9

Q28079823-04334073-196C-47C5-8072-5155D9C463B7

Q28079823-0547F4AE-86EF-40AE-81F1-33ABD8755EBD

Q28079823-0605EE87-E6CC-4CA3-ACB3-8C6BA0BE0471

Q28079823-08952004-1A12-4097-BC8A-5251B4023079

Q28079823-0A942AD6-17B4-431A-8663-F0DE9E92F20C

Q28079823-0B071EAE-2FB6-449E-9C99-5D00CEC51887

P304

Q28079823-745960EE-9B7C-47DE-8C8A-E2BF3CA22688

P31

Q28079823-7924ADD9-EF16-41F6-A4A0-368982CD3190

P3181

Q28079823-21931796-BCF9-4768-8099-A212501DBFF3

P356

Q28079823-9D1DB49D-4743-4102-BC36-B8855AD31831

P407

Q28079823-3AA0E738-C485-450E-86CB-E0037371CF35

P478

Q28079823-D66B8580-55CB-4EE6-9831-6B2CF386ABD5

P577

Q28079823-9CA4AD11-B55A-4D91-AEE0-FFBF4F19B17E

P698

Q28079823-68624CE2-D0D6-4C32-8BE8-B9F768BF0A2D

P921

Q28079823-26CCE871-AC37-430D-9B9F-F69C98D73AE9

P932

Q28079823-365C749B-E14E-4603-B63B-31C4E2BAE60B

P3181

P356

FIMMU.2016.00500

P1433

Frontiers in Immunology

P1476

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

@en

P2093

Anne Mary Dickinson

http://www.w3.org/2001/XMLSchema#string

Anne Richter

http://www.w3.org/2001/XMLSchema#string

Eva M. Weissinger

http://www.w3.org/2001/XMLSchema#string

Justyna Ogonek

http://www.w3.org/2001/XMLSchema#string

Liane Preußner

http://www.w3.org/2001/XMLSchema#string

Lindsay Nicholson

http://www.w3.org/2001/XMLSchema#string

Marsela Qesari

http://www.w3.org/2001/XMLSchema#string

Monica Reis

http://www.w3.org/2001/XMLSchema#string

Nuno M. Borges

http://www.w3.org/2001/XMLSchema#string

Xiao-nong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and proteomic profiling of exosomes in human urine

Exosomal-like vesicles are present in human blood plasma

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs

B lymphocytes secrete antigen-presenting vesicles

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer

Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy

Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy

Adoptive T-cell therapy for fungal infections in haematology patients

Infectious Mononucleosis

P304

500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2570812

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FIMMU.2016.00500

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27895644

http://www.w3.org/2001/XMLSchema#string

P921

P932

5107577

http://www.w3.org/2001/XMLSchema#string